CapWealth Advisors’s GSK GSK Stock Holding History

CapWealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-128	Closed	-$7K	–	159
2016 Q3	$7K	Buy	128 +3	+2%	+$164	﹤0.01%	231
2016 Q2	$7K	Hold	125	–	–	﹤0.01%	227
2016 Q1	$6K	Hold	125	–	–	﹤0.01%	269
2015 Q4	$6K	Sell	125 -5	-4%	-$255	﹤0.01%	215
2015 Q3	$6K	Hold	130	–	–	﹤0.01%	215
2015 Q2	$7K	Hold	130	–	–	﹤0.01%	226
2015 Q1	$8K	Buy	+130	New	+$7.45K	﹤0.01%	232
2014 Q4	–	Sell	-130	Closed	-$7K	–	169
2014 Q3	$7K	Hold	130	–	–	﹤0.01%	262
2014 Q2	$9K	Sell	130 -160	-55%	-$10.8K	﹤0.01%	246
2014 Q1	$19K	Hold	290	–	–	0.01%	196
2013 Q4	$19K	Sell	290 -248	-46%	-$16.1K	﹤0.01%	212
2013 Q3	$34K	Hold	538	–	–	0.01%	184
2013 Q2	$34K	Buy	+538	New	+$34.1K	0.01%	177

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CapWealth Advisors's GSK Position: Q4 2016 in Review

CapWealth Advisors sold out of GSK (GSK) in Q4 2016, closing a stake of 128 shares — an estimated $7K sold.

CapWealth Advisors first reported a position in GSK in Q2 2013 and held it in 13 quarters. The position peaked at $34K in Q3 2013. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

CapWealth Advisors reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
CapWealth Advisors sold 128 GSK shares in Q4 2016, an estimated $7K.
CapWealth Advisors first reported a position in GSK in Q2 2013 and held it in 13 quarters.
CapWealth Advisors's GSK position peaked at $34K in Q3 2013.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on CapWealth Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.